Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,116 | -27,970 | -20,283 | -13,779 | -9,049 |
| Depreciation Amortization | 191 | 772 | 575 | 376 | 189 |
| Accounts receivable | -252 | 425 | 473 | 473 | 268 |
| Accounts payable and accrued liabilities | -583 | 1,769 | 1,633 | 1,378 | 608 |
| Other Working Capital | -2,265 | 1,012 | 1,477 | 990 | 14 |
| Other Operating Activity | 1,508 | 1,646 | 961 | 492 | 753 |
| Operating Cash Flow | $3,715 | $-22,346 | $-15,164 | $-10,070 | $-7,217 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -50 | -6 | -4 | -4 |
| Investing Cash Flow | $N/A | $-50 | $-6 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,476 | 2,476 | 361 | N/A |
| Common Stock Issued | 103 | 28,782 | 7,960 | 7,917 | 7,490 |
| Other Financing Activity | 0 | 367 | 0 | 0 | 0 |
| Financing Cash Flow | $103 | $31,625 | $10,436 | $8,278 | $7,490 |
| Beginning Cash Position | 21,295 | 12,066 | 12,066 | 12,066 | 12,066 |
| End Cash Position | 25,113 | 21,295 | 7,332 | 10,270 | 12,335 |
| Net Cash Flow | $3,818 | $9,229 | $-4,734 | $-1,796 | $269 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,715 | -22,346 | -15,164 | -10,070 | -7,217 |
| Capital Expenditure | N/A | -50 | -6 | -4 | -4 |
| Free Cash Flow | 3,715 | -22,396 | -15,170 | -10,074 | -7,221 |